FTC to look into drugmakers and wholesalers

Korea’s antitrust regulator has embarked on looking into the pricing collusion of pharmaceutical companies and wholesalers following the recent drug bidding failure in Seoul National University Hospital.

The Fair Trade Commission (FTC) said on March 15 that the business regulator has decided to look into problems from the illegal collusion of drug makers and wholesalers in terms of competiti...